Landegren U, Ramstedt U, Axberg I, Ullberg M, Jondal M, Wigzell H
J Exp Med. 1982 May 1;155(5):1579-84. doi: 10.1084/jem.155.5.1579.
Out of a panel of seven monoclonal antibodies with affinity for human lymphoid cells, three were shown to prevent cytotoxic T cell activity, whereas none affected natural killer cell activity when applied without complement. Anti-OKT3 and anti-Leu-2a, with affinity for all T cells and the cytotoxic/suppressive subset, respectively were both shown to inhibit T killing by their interaction with the effector cell. For anti-OKT3, the inhibition remained after free antibody was washed away. Anti-Leu-2a, in contrast, induced a rapidly reversible inhibition. Using a single cell assay, anti-OKT3 was shown to reduce the lytic ability without affecting target cell binding, whereas anti-Leu-2a prevented the effectors from binding target cells.
在一组对人淋巴细胞具有亲和力的七种单克隆抗体中,有三种被证明可阻止细胞毒性T细胞的活性,而在无补体情况下应用时,没有一种会影响自然杀伤细胞的活性。分别对所有T细胞和细胞毒性/抑制性子集具有亲和力的抗OKT3和抗Leu-2a,均通过与效应细胞相互作用而抑制T细胞杀伤作用。对于抗OKT3,在洗去游离抗体后抑制作用仍然存在。相比之下,抗Leu-2a诱导的抑制作用迅速可逆。使用单细胞试验表明,抗OKT3可降低裂解能力而不影响靶细胞结合,而抗Leu-2a则阻止效应细胞与靶细胞结合。